Skip to main content
. 2022 Apr 25;9:841876. doi: 10.3389/fmed.2022.841876

TABLE 1.

Summary of studies included in systematic review and meta-analysis.

References Publication type Location Design Number of hospitals No. patients enrolled by study arm
DyeVert System Control
Desch et al. (27) Manuscript Germany P, RCT 1 (DyeVert)
48
(Manual injection)
48
Bath et al. (29) Abstract United States P, RCT 1 (DyeVert Plus)
49
(Manual injection)
59
Briguori et al. (30) Manuscript Italy R, O, PMC 1 (DyeVert Plus EZ)
90
(Manual injection)
90
Sattar et al. (31) Abstract United States R, O 1 (DyeVert Plus)
41
(Manual injection)
68
Kutschman (32) Abstract United States R, O 1 (DyeVert Plus & DyeVert Plus EZ)
128
(Manual injection
78
Kutschman et al. (33) Abstract United States R, O 1 (DyeVert Plus & DyeVert Plus EZ)
258
(Manual injection)
243
Bunney et al. (34) Abstract United States R, O 1 (DyeVert Plus & DyeVert Plus EZ)
29
(Manual injection)
770
Tajti et al. (35) Manuscript United States R, O 1 (DyeVert Plus)
40
(Manual injection)
94
Zimin et al. (36) Manuscript United States P, O 1 (DyeVert Plus EZ)
16
(Manual injection with OCT imaging)
15
Sapontis et al. (37) Manuscript Germany, Australia P, O 2 (DyeVert)
44
None
Corcione et al. (38) Manuscript Italy R, O 1 (DyeVert Plus)
10
None
Gurm et al. (39) Manuscript United States P, O 8 (DyeVert Plus)
114
None
Turner and Tucker (40) Abstract United States R, O 1 (DyeVert Plus & DyeVert Plus EZ)
536
None
Cameron and Espinosa (41) Abstract United States R, O 1 (DyeVert Plus & DyeVert Plus EZ)
423
None
Rao (42) Abstract United States R, O 1 (DyeVert Plus)
7
None
Amoroso et al. (43) Abstract Netherlands, Germany, United
Kingdom
R, O 3 (DyeVert Power XT)
26
None
Bruno et al. (28) Manuscript Germany R, O 1 (DyeVert Power XT)
9
None

O, observational; OCT, optical coherence tomography; P, prospective; PMC, propensity-matched control; R, retrospective; RCT, randomized controlled trial.